QRS interval

Related by string. * QRs . qr : QR code sophisticated . QRS Catalogue . QR Reds . QRS duration . QR code reader . scanning QR codes . scan QR code . QR Code Reader . Rail QR / Intervals . INTERVAL . intervals . Interval : confidence interval #.#-#.# . confidence interval CI . assay intervals . Interval Leisure Group . dosing interval . dosing intervals . interval grading . QT interval . QT interval prolongation * *

Related by context. All words. (Click for frequent words.) 71 QRS duration 67 Tasigna prolongs 66 QT intervals 66 hemodynamic variables 65 pretransplant 65 creatine kinase MB 64 eosinophil count 64 dyssynchrony 64 bi ventricular pacing 64 cTnI 64 cardiac repolarization 64 hypoperfusion 63 angiographically 63 thyroid carcinoma 63 mutated K ras 63 intraventricular 63 myocardial infarct size 62 corrected QT interval 62 autoregulation 62 colorectal adenoma 62 repolarization 62 hyperacute 62 gene polymorphism 62 LV dysfunction 62 endothelial activation 62 CK MB 62 QRS width 62 renal cysts 62 cardiac troponin 62 tissue oxygenation 62 myocardial necrosis 62 LVSD 62 activated partial thromboplastin 62 atherothrombotic 62 thickness IMT 62 leukocyte counts 62 echocardiographic parameters 61 metaplasia 61 intact parathyroid hormone 61 electrophysiologic 61 F FDG PET 61 FDG uptake 61 gastric cardia 61 contractile function 61 HER2 expression 61 pretest probability 61 cerebral vasospasm 61 ERalpha 61 hematological relapse 61 SCr 61 QT QTc 61 intracardiac 61 liver metastasis 61 aminotransferase 61 Ventricular Tachycardia 61 prospective multicenter study 61 bronchoalveolar lavage fluid 60 NMIBC 60 endothelium dependent 60 bronchial hyperresponsiveness 60 lymph node metastasis 60 distensibility 60 gadolinium enhanced 60 prognostic significance 60 artery stenosis 60 CSF biomarkers 60 troponin T 60 hyperalgesia 60 bronchoalveolar lavage 60 transabdominal 60 Brugada syndrome 60 microvessel 60 QT QTc interval 60 esophageal carcinoma 60 intracerebral 60 ischemic penumbra 60 Hypotension 60 coronary stenosis 60 Plasma concentrations 60 radiotherapy RT 60 left ventricular LV 60 monophasic 60 electrocardiography ECG 60 Ejection Fraction 60 carotid plaque 60 ventricular repolarization 60 electrocardiographic 60 secondary efficacy endpoint 60 mediated inhibition 60 narrow QRS 60 intima media thickness 60 lactate dehydrogenase 60 aminotransferases 60 adrenocortical 60 fraction LVEF 60 infarct size 60 cardioplegic arrest 60 normoxic 60 thyroglobulin 60 LV ejection fraction 60 biochemical relapse 60 cardioverter defibrillator 60 AV node 60 progression TTP 60 tumor histology 59 colocalization 59 prostate carcinoma 59 TOP2A 59 denervation 59 PSA nadir 59 glomerular 59 ventricular remodeling 59 microcirculatory 59 thoracic aortic aneurysm 59 myocardial fibrosis 59 pT3 59 nodal metastasis 59 paroxysmal AF 59 nerve conduction velocity 59 histological subtype 59 nondiabetic patients 59 posttransplant 59 tracheal intubation 59 Subarachnoid hemorrhage 59 biochemical recurrence 59 plasma renin activity 59 serum cortisol 59 intracoronary 59 carcinoids 59 atrioventricular 59 chronic thromboembolic pulmonary 59 QTc prolongation 59 ventricular arrhythmia 59 metabolite concentrations 59 metastatic malignant 59 transgene expression 59 parasitemia 59 inotropic 59 multivariate Cox 59 cerebral ischemia 59 hemodilution 59 epididymal 59 multivariable analysis 59 stratifying patients 59 QT interval 59 atrial pacing 59 variant angina 59 Prognostic factors 59 hypervascular 59 sinus node dysfunction 59 haematologic 59 biventricular 59 lactate dehydrogenase LDH 59 intima media thickness IMT 59 Skin sterol 59 ptau 59 cardiac perfusion 59 cardiac dysfunction 59 diffusivity 59 myocardial ischemia 59 locoregional recurrence 59 PSADT 59 gefitinib Iressa 59 corneal curvature 59 transcranial Doppler 59 arteriography 59 ejection fractions 59 prolonged QT interval 59 myocardial function 59 edifoligide 59 thrombocytopenic 59 preserved ejection fraction 59 prostate cancer PCa 59 dysfunction LVSD 59 Circulating tumor cells 59 thyrotropin 59 plasma lipids 59 degranulation 59 transthoracic 59 ‰ ¥ 59 nonvascular 59 leukocyte count 59 defibrillator implant 59 underwent resection 59 peri procedural 59 QTc interval 59 colorectal carcinoma 59 arterial oxygen saturation 59 myocardial viability 59 recombinant tissue plasminogen 59 cerebral perfusion 59 CP CPPS 59 T1a 59 manometry 59 antibody titer 59 lowest tertile 59 cardiac magnetic resonance 58 perfusion defects 58 Diabetic nephropathy 58 chemosensitivity 58 neovascular 58 arterial calcification 58 potentiation 58 IIIb 58 arrhythmogenic 58 nonischemic 58 fibrin deposition 58 serum aminotransferase levels 58 thromboembolic complications 58 hemoglobin Hb 58 leptin deficiency 58 computed tomographic angiography 58 seminal vesicle invasion 58 nicardipine 58 Intracoronary 58 cisplatin resistant 58 ADPKD 58 malignant neoplasm 58 nonfatal MI 58 arterial occlusion 58 adrenalectomy 58 plasmid encoding 58 albumin excretion rate 58 FDG PET imaging 58 rate variability HRV 58 shortens systolic ejection 58 Myoglobin 58 induced sputum 58 radioimmunoassay 58 tryptase 58 uricase 58 hypoxemia 58 neurologic progression 58 ischemic cardiomyopathy 58 electroencephalographic 58 transcranial Doppler ultrasound 58 non valvular atrial 58 Lp PLA 2 58 Heavy menstrual bleeding 58 ventricular dyssynchrony 58 aortic regurgitation 58 umbilical artery 58 biochemical marker 58 Myocardial Infarction TIMI 58 systolic dysfunction 58 intrathoracic 58 isoenzyme 58 serum concentrations 58 Doppler sonography 58 autonomic dysfunction 58 murine model 58 atrioventricular block 58 peripheral insulin sensitivity 58 natriuretic peptide 58 pancreatic ductal 58 elevated transaminases 58 intrahepatic 58 adrenocorticotropic hormone 58 undergoing coronary artery 58 platelet dysfunction 58 gene amplification 58 cytochrome oxidase 58 μg liter 58 lesional 58 Interferon beta 58 histologic subtype 58 Atherosclerotic 58 ventilation perfusion 58 metastatic lymph nodes 58 preterm neonates 58 CD# expression [002] 58 ischemia induced 58 coronary artery occlusion 58 rebleeding 58 ischemic lesions 58 deep venous thromboses 58 ABCB1 58 prognostic indicator 58 Duodenal 58 CYP#D# genotype 58 pulmonary arterial 58 mitral stenosis 58 adenomatous 58 hMG 58 SGRQ 58 thromboxane A2 58 myometrium 58 pulmonary artery banding 58 calcified plaques 58 Intravascular 58 thrombotic complications 58 anemia thrombocytopenia 58 inotropic agents 58 cTnT 58 administered intraperitoneally 58 acute ischemia 58 thrombus aspiration 58 myocardial ischaemia 58 graft patency 58 Ventricular fibrillation 58 HIV HCV coinfected 58 Fontan procedure 58 AST ALT 58 TIMP 1 58 QTc 58 coagulation abnormalities 58 catheter angiography 58 interleukin IL -# 58 isoprostane 58 exhaled NO 58 transcatheter closure 58 invasive angiography 58 etiologic 58 asystole 58 resynchronization therapy 58 immunostaining 58 spirometric 58 allogeneic HSCT 58 independent prognostic marker 58 Papillary 58 computed tomography angiography 58 epicardial 58 biliary tract cancer 58 RRM1 58 biventricular pacing 58 intra arterial 58 cardiac conduction 58 postoperative AF 58 PaO 2 58 histopathologic diagnosis 58 carotid intima media 58 IL#B 57 hematological parameters 57 cardiac troponin T 57 intravascular volume 57 allograft rejection 57 hyperintensity 57 QT Prolongation 57 gastrointestinal perforation 57 circadian genes 57 serum albumin 57 Leydig cell 57 cytopenias 57 Alanine 57 vessel occlusion 57 Scintigraphy 57 vasodilatation 57 cardiac contractility 57 CRT ICD 57 ascending aortic 57 liver resection 57 telomere lengths 57 angiogenic therapy 57 periprocedural 57 Figure 1C 57 periprocedural MI 57 gastroduodenal 57 hyperintense lesions 57 RVOT 57 radiosensitivity 57 p = #.# [003] 57 cerebral oxygenation 57 surgically resected 57 left ventricular dysfunction 57 FFR measurements 57 STRIDE PD 57 Glomerular filtration rate 57 diabetic kidney 57 urothelial carcinoma 57 constipation predominant IBS 57 femoral neck fracture 57 Am J Cardiol 57 acidic reflux 57 interleukin IL -6 57 transient elastography 57 beta1 integrin 57 preoperative PSA 57 hyperparathyroidism 57 postoperative complication 57 peritumoral 57 cisplatin vinorelbine 57 pain palliation 57 Ischemic 57 Hypertrophy 57 antigen PSA levels 57 esophagogastric 57 cerebrovascular events 57 deoxy 57 lung epithelium 57 idiopathic pulmonary arterial hypertension 57 nmol liter 57 myeloid metaplasia 57 murine models 57 metabolizing enzyme 57 neutrophil counts 57 fig. S2 57 arterial inflammation 57 Hyperlipidemia 57 ipsilateral stroke 57 natriuretic peptides 57 oxygen saturation SpO2 57 pamidronate 57 stenotic 57 sub maximal 57 symptomatic VTE 57 antiangiogenic therapy 57 bullous 57 selective cerebral perfusion 57 mesenteric 57 acute aortic dissection 57 androgen ablation 57 β blockers 57 transvenous 57 metachronous 57 thromboembolic 57 diabetes mellitus DM 57 perfusion imaging 57 pT2 57 morphologic characteristics 57 systemic hypotension 57 Renal Insufficiency 57 rCBF 57 percutaneous biopsy 57 gene polymorphisms 57 Diastolic 57 fulminant hepatic failure 57 malignant ascites 57 Patency 57 Inhaled nitric oxide 57 MMSE score 57 hilar 57 #OHD 57 bioavailable testosterone 57 QTcF 57 cardioembolic stroke 57 recurrent venous thromboembolism 57 laser Doppler 57 intravascular ultrasonography 57 extracapsular extension 57 differential gene expression 57 Chronic pancreatitis 57 bronchoalveolar lavage BAL 57 CR nPR 57 prognostic marker 57 tertile 57 pleiotropic effects 57 silent myocardial ischemia 57 oxyhemoglobin 57 Tumor Response 57 epoetin alpha 57 serum markers 57 core needle biopsies 57 SGPT 57 digital subtraction angiography 57 ultrasonographic examination 57 pathologic fracture 57 intratumoral 57 prostate cancer CaP 57 histopathologic examination 57 contractility 57 prothrombotic 57 valvular heart disease 57 receptor blocker 57 KRAS mutation status 57 Subgroup analysis 57 plasminogen activator inhibitor 57 #Gy 57 mitral annular 57 postoperative mortality 57 thrombocytosis 57 serum TSH 57 mucinous 57 bronchoscopic 57 physiologic parameters 57 operable breast cancer 57 vertebrobasilar 57 crossclamp 57 Hemodynamic 57 fractional shortening 57 aminotransferase ALT 57 intraluminal 57 left ventricular systolic 57 Immunohistochemical staining 57 fibrinolysis 57 Ultrasonography 57 ischaemia 57 VKORC1 57 hypermethylated 57 troponins 57 Annexin V 57 Estrogen Receptor 57 endoscopic ultrasonography 57 antiphospholipid syndrome 57 lymphocyte count 57 surrogate markers 57 balloon valvuloplasty 57 Cardiorespiratory fitness 57 CYP#A# substrates 57 SUVmax 57 diagnostic biomarker 57 drug eluting stent implantation 57 hyperintensities 57 hibernating myocardium 57 Figure 2C 57 opacification 57 recurrent glioblastoma multiforme 57 GI motility 57 cellularity 57 glycosylated hemoglobin HbA1c 57 carcinoembryonic antigen 57 serum urate levels 57 thrombus formation 57 undergoing CABG 57 Figure 1A 57 intestinal permeability 57 cardiopulmonary bypass CPB 57 correlated inversely 57 ApoB protein 57 Prognostic significance 57 renal pelvis 57 malignant nodules 57 triiodothyronine 57 endobronchial 57 creatinine ratio 57 MGd 57 Adjuvant therapy 57 splanchnic 56 papillary renal cell carcinoma 56 baroreceptors 56 Troponin T 56 endometrial thickness 56 pulmonary artery pressure 56 histologically proven 56 EGFR mutation status 56 haematopoietic 56 tertiles 56 hyperplastic 56 pulmonary metastases 56 nitrotyrosine 56 renal artery stenting 56 Arrhythmogenic 56 timepoints 56 cardiac biomarkers 56 uM 56 cervical lymph nodes 56 experimentally induced 56 pulmonary resection 56 PAOD 56 adiponectin concentrations 56 KRAS mutation 56 ventricular fibrillation VF 56 K ras mutations 56 airway hyperresponsiveness 56 superficial femoral 56 Doppler echocardiography 56 noncardiac 56 FDG-PET/CT 56 lymphocyte counts 56 estimated glomerular filtration 56 zoledronate 56 patientswith 56 autoantibody levels 56 DHCA 56 parkinsonian 56 vasopressor 56 noncoronary 56 transcranial 56 blood clotting protein 56 artery occlusion 56 P = .# 56 mL/min/#.# m 2 56 pressure natriuresis 56 urinary N telopeptide 56 radiographic progression 56 Atrial 56 thyrotropin levels 56 torsade de pointes 56 glomerular filtration 56 Transesophageal 56 diffusion tensor 56 rt PA 56 Doppler ultrasonography 56 bacillus Calmette Guerin 56 tumor resection 56 androgen suppression 56 Orthostatic hypotension 56 ultrasonographic 56 glycated hemoglobin levels 56 fructosamine 56 endothelin antagonists 56 specific antigen PSA 56 NF kappaB activation 56 supratentorial 56 busulfan 56 PITX2 56 baroreflex sensitivity 56 mitochondrial respiration 56 neurologic deficits 56 Histologic 56 transdermal estradiol 56 metabolic parameters 56 NOD SCID mice 56 induce remission 56 underwent surgical resection 56 diastolic blood pressures 56 aneurysmal 56 brain parenchyma 56 transesophageal echocardiography 56 nimodipine 56 pacemaker implantation 56 urine albumin 56 Doppler imaging 56 antiangiogenic agent 56 baroreflex 56 color Doppler ultrasound 56 Univariate analysis 56 null mice 56 Coronary Artery Bypass Graft 56 silent ischemia 56 Partial Response 56 thrombo embolic 56 survivin expression 56 inhibiting COX 56 levodopa induced 56 NYHA functional class 56 metastatic gastric 56 subthalamic 56 pretreatment serum 56 resuscitated cardiac arrest 56 liposome formulation 56 bacterial prostatitis 56 poor metabolizers 56 mCi 56 underwent coronary angiography 56 myeloperoxidase 56 immunohistochemical analysis 56 aggregometry 56 amyloid plaque formation 56 sural nerve 56 arteriolar 56 central corneal thickness 56 aPTT 56 leukocytosis 56 hypothalamic pituitary adrenal axis 56 mediastinal lymph nodes 56 chromosome #p# [002] 56 HSCT 56 ischemia driven 56 COL#A# 56 aspartate aminotransferase 56 leucopenia 56 hemodynamic parameters 56 Temsirolimus 56 hypothalamic pituitary 56 #.#ng/ml 56 Stent thrombosis 56 serum lipid 56 postop 56 PTHrP 56 euthyroid 56 Serum concentrations 56 biliary obstruction 56 transcutaneous 56 trophoblast cells 56 baseline LDH 56 GORE TAG Device 56 biphasic 56 conduction abnormalities 56 unmutated 56 serum BDNF 56 leiomyomas 56 pancreatic adenocarcinoma 56 myocardial perfusion 56 renal artery stenosis 56 HER2 overexpression 56 hormone receptor status 56 thymectomy 56 hemodynamically significant 56 SpO 2 56 diabetes dyslipidemia 56 sitaxsentan 56 adenoma recurrence 56 neointimal hyperplasia 56 coagulopathy 56 obstructive coronary artery 56 Postoperative 56 SNP rs# [001] 56 aT cell 56 Breslow thickness 56 electrical cardioversion 56 CEACAM1 56 severe neutropenia 56 intracranial stenosis 56 PRADAXA #mg 56 monogenic 56 EGFR TKI 56 atheroma volume 56 diagnose coronary artery 56 CC genotype 56 pharmacodynamic effects 56 intraperitoneally 56 schwannomas 56 tumorigenicity 56 Ventricular tachycardia 56 hypoxia induced 56 bypass grafting 56 submucosal 56 aortic root replacement 56 mineralocorticoid 56 PLX STROKE targeting 56 multivariable Cox 56 paricalcitol 56 helical CT 56 genes differentially expressed 56 Ancrod 56 SPECT CT imaging 56 carotid artery blockage 56 myocardial revascularization 56 p# biomarker 56 stimulated insulin secretion 56 PICSO ® 56 afterload 56 recurrent laryngeal nerve 56 CTEPH 56 procalcitonin 56 mL kg 56 ultrastructural 56 DNA methylation patterns 56 deCODE AF TM 56 viral nucleic acids 56 mild renal insufficiency 56 QTc intervals 56 SpO2 56 lung metastasis 56 Leukemias 56 osteoblastic 56 postoperative pulmonary 56 carotid artery intima media 56 detrusor 56 OGTT 56 node metastases 56 ionotropic 56 inflammatory cytokine 56 endocrinologic 56 Cardiopulmonary bypass 56 FFR measurement 56 seminomas 56 caval 56 submandibular gland 56 eptifibatide 56 multivariate analyzes 56 computed tomographic scans 56 MMP inhibitor 56 steroidogenic 56 Cotinine 56 impair fertility 56 rFVIIa 56 tirofiban 56 atheroma 56 ABL1 56 revascularisation procedures 56 milrinone 56 NSTEMI 56 Pharmacokinetic studies 56 serum homocysteine 56 TUMT 56 hypercapnia 56 BrachySil ™ 56 jugular venous 56 D dimer 56 antiarrhythmic medications 56 prognostic variables 56 recovery CRp 56 Creatinine 56 nodal metastases 56 inhaled iloprost 56 miRNA expression 56 hepatorenal syndrome 56 PEG IFN 56 NATRECOR ® 56 curative resection 56 Endothelial dysfunction 56 GI toxicity 56 conditional logistic regression 56 transvaginal sonography 56 coronary vasculature 56 occlusive disease 56 transfusion syndrome 56 lipoprotein levels 56 symptomatic intracranial 56 renal tubular 56 Myocardial Infarction 56 viral titers 56 Systolic 56 plasma renin 56 cerebral oxygen saturation 56 periventricular 56 bolus dose 56 cytoreduction 56 dobutamine 56 hypothalamic pituitary axis 56 mitral valve regurgitation 56 extramedullary 56 Computed tomography 56 baseline FEV 56 pathologic diagnosis 56 Electrophysiological 56 glycaemia 56 morphometric vertebral fractures 55 MMP# 55 sarcomatoid 55 contrast echocardiography 55 thickness CIMT 55 lethal arrhythmias 55 #mmHg [001] 55 prespecified secondary 55 coronary revascularization 55 peritoneal fluid 55 pulmonary angiography 55 CD# expression [001] 55 epithelial tumors 55 nonfatal myocardial infarction MI 55 heterozygotes 55 eNO 55 NNT = 55 daily subcutaneous injections 55 alpha1 antitrypsin deficiency 55 hippocampal atrophy 55 systolic function 55 truncal 55 antiarrhythmic 55 serum sodium levels 55 MDRD 55 elevated LDH 55 microvascular disease 55 TURBT 55 proton MR spectroscopy 55 bladder carcinoma 55 transaminase levels 55 antitrypsin 55 hypericin 55 prostatic tissue 55 Index CDAI 55 Cardiotoxicity 55 HOMA IR 55 acetazolamide 55 abnormal glucose metabolism 55 rtPA 55 Lymph node 55 lung nodule 55 systolic diastolic 55 HLA DR4 55 indirect calorimetry 55 graft dysfunction 55 Coronary artery calcium 55 cardiac allograft vasculopathy 55 E selectin 55 Peripheral Arterial 55 salivary cortisol 55 mecamylamine 55 N telopeptide 55 aortic insufficiency 55 beta adrenergic receptor 55 cytokeratin 55 pCR 55 aneurysm rupture 55 platelet reactivity 55 hepatic enzyme 55 λ 55 atherosclerotic coronary 55 Paliperidone 55 pathologic examination 55 hepatic fibrosis 55 perfusion abnormalities 55 NSCLC tumors 55 vascular reactivity 55 postprocedure 55 interquartile range 55 nmol 55 percutaneous transluminal coronary angioplasty 55 proximal colon 55 intermittent hypoxia 55 Randomized Evaluation 55 Secondary endpoints include 55 Electroencephalography EEG 55 carcinoid tumor 55 IL6 55 coronary anatomy 55 systemic toxicity 55 erythropoiesis 55 circulating lymphocytes 55 endoleaks 55 VT VF 55 serum triglycerides 55 micrometastasis 55 aspartate aminotransferase AST 55 extubation 55 μmol L 55 echocardiographic 55 Legg Calvé Perthes disease 55 vasculopathy 55 gastric adenocarcinoma 55 ipsilateral 55 viral tropism 55 radiochemotherapy 55 p# activation 55 endoscopic resection 55 myocardial contractility 55 plasma pharmacokinetics 55 glucocorticoid induced 55 cranial irradiation 55 microsomal 55 LPS induced 55 KRAS oncogene 55 stereotactic radiotherapy 55 logistic regression analyzes 55 inotropes 55 cryptogenic 55 hepatic encephalopathy HE 55 MADIT II 55 Cystatin C 55 elevated IOP 55 pheochromocytoma 55 Kinoid 55 carotid IMT 55 nasal polyposis 55 CRp 55 corneal thickness 55 atrial arrhythmias 55 postoperative radiotherapy 55 Viral load 55 Carvedilol 55 pairwise comparisons 55 neuroregenerative 55 BEXXAR Therapeutic Regimen 55 vaso occlusive crisis 55 antitumor effect 55 pulmonary metastasis 55 micronuclei 55 splenic 55 Infarct 55 glucose sensor 55 VADT 55 residual platelet reactivity 55 flow mediated dilation 55 pmol L 55 p = NS 55 biochemical abnormalities 55 axial length 55 RT PCR assay 55 interobserver reliability 55 mg/m2 dose 55 ASTEROID 55 mediastinal 55 residual stenosis 55 ventricular myocardium 55 DAS# CRP 55 anastomotic leak 55 Subclinical 55 bypass graft CABG surgery 55 intramyocardial 55 metabolic dysfunction 55 cortical activation 55 circulating EPCs 55 ischemia reperfusion 55 MAGE A3 ASCI 55 streptokinase 55 suprapubic 55 fasting triglycerides 55 aminophylline 55 malperfusion 55 ligand receptor 55 urolithiasis 55 dose dependently 55 cardiotoxic 55 transesophageal 55 Intrathecal 55 pyridostigmine 55 sensitivity specificity 55 antiarrhythmics 55 tubule 55 Pegylated Liposomal Doxorubicin 55 microelectrode array 55 Preoperatively 55 reinfarction 55 coronary stenoses 55 anticholinergic agents 55 AV fistulas 55 receptor antagonism 55 parenchymal 55 magnetic resonance CMR 55 vasomotor 55 chromosome #q# [002] 55 inhibit platelet function 55 thoracic aortic 55 glomerular filtration rate 55 endometrial hyperplasia 55 postintervention 55 ALT elevation

Back to home page